NASDAQ : BOLT
Bolt Biotherapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 6.36 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.25M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Bolt Biotherapeutics, Inc. (BOLT) reported revenue of 4.70M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 4.70M | 7.70M | 7.69M | 7.88M | 5.73M | 1.26M |
| Cost of Revenue | 21.50M | 28.53M | 57.47M | 61.54M | 73.12M | 75.66M |
| Gross Profit | -16.80M | -20.84M | -49.78M | -53.67M | -67.39M | -74.39M |
| Selling, General & Admin | 11.67M | 13.79M | 18.46M | 22.53M | 22.93M | 18.39M |
| Operating Expenses | 11.67M | 13.79M | 18.46M | 22.53M | 22.93M | 18.39M |
| Operating Income | -28.48M | -34.63M | -68.24M | -76.20M | -90.32M | -92.79M |
| Interest & Investment Income | 1.30M | 2.50M | 5.25M | 7.00M | 2.22M | 281.00K |
| Other Non Operating Income (Expenses) | 726.00K | 241.00K | -6.08M | |||
| EBT Excluding Unusual Items | -26.45M | -31.90M | -62.98M | -69.20M | -88.10M | -98.59M |
| Merger & Restructuring Charges | -1.48M | -1.48M | -3.34M | |||
| Asset Writedown | -808.00K | -1.47M | ||||
| Other Unusual Items | 4.67M | |||||
| Pretax Income | -28.74M | -33.38M | -63.12M | -69.20M | -88.10M | -98.59M |
| Net Income | -28.74M | -33.38M | -63.12M | -69.20M | -88.10M | -98.59M |
| Net Income to Common | -28.74M | -33.38M | -63.12M | -69.20M | -88.10M | -98.59M |
| Shares Outstanding (Basic) | 1.75M | 1.87M | 1.91M | 1.89M | 1.87M | 1.66M |
| Shares Outstanding (Diluted) | 1.75M | 1.87M | 1.91M | 1.89M | 1.87M | 1.66M |
| EPS (Basic) | -16.38 | -17.85 | -33.06 | -36.60 | -47.16 | -59.40 |
| EPS (Diluted) | -16.38 | -17.85 | -33.06 | -36.60 | -47.16 | -59.40 |
| Free Cash Flow | -31.54M | -39.92M | -61.33M | -69.73M | -78.46M | -59.40M |
| Free Cash Flow Per Share | -17.98 | -21.35 | -32.12 | -36.88 | -42.00 | -35.79 |
| Gross Margin | -270.80% | |||||
| Operating Margin | -605.85% | -450.07% | -887.33% | -967.45% | -1,576.56% | -7,364.13% |
| Profit Margin | -611.47% | -433.74% | -820.78% | -878.58% | -1,537.75% | -7,824.68% |
| Free Cash Flow Margin | -670.98% | -518.80% | -797.53% | -885.36% | -1,369.47% | -4,714.60% |
| EBITDA | -27.56M | -33.34M | -66.45M | -74.34M | -88.66M | -91.59M |
| D&A For EBITDA | 919.00K | 1.29M | 1.78M | 1.85M | 1.67M | 1.19M |
| EBIT | -28.48M | -34.63M | -68.24M | -76.20M | -90.32M | -92.79M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 12.86M | 11.70M | 7.21M | 10.81M | 9.24M | 27.38M |
| Short-Term Investments | 4.74M | 15.80M | 40.12M | 91.38M | 159.64M | 158.84M |
| Cash & Short-Term Investments | 17.60M | 27.50M | 47.32M | 102.19M | 168.89M | 186.22M |
| Other Receivables | 13.00K | 973.00K | 1.17M | 600.00K | ||
| Receivables | 13.00K | 973.00K | 1.17M | 600.00K | ||
| Prepaid Expenses | 2.75M | 1.41M | 1.49M | 2.74M | 3.86M | 2.94M |
| Restricted Cash | 200.00K | 200.00K | 784.00K | |||
| Other Current Assets | 175.00K | 55.00K | 178.00K | |||
| Total Current Assets | 20.56M | 30.26M | 50.81M | 105.71M | 172.75M | 189.16M |
| Property, Plant & Equipment | 17.65M | 20.48M | 24.89M | 24.08M | 28.52M | 30.60M |
| Long-Term Investments | 509.00K | 4.34M | 22.88M | 26.41M | 23.94M | 85.35M |
| Long-Term Deferred Charges | 137.00K | 51.00K | 371.00K | |||
| Other Long-Term Assets | 1.62M | 1.54M | 992.00K | 3.21M | 2.59M | 2.61M |
| Total Assets | 40.34M | 56.75M | 99.63M | 159.78M | 227.81M | 307.72M |
| Accounts Payable | 868.00K | 1.44M | 1.51M | 2.99M | 3.59M | 3.57M |
| Accrued Expenses | 3.06M | 2.97M | 8.34M | 12.49M | 15.14M | 12.38M |
| Current Portion of Leases | 3.09M | 2.83M | 2.25M | 2.78M | 2.39M | 2.50M |
| Current Unearned Revenue | 819.00K | 449.00K | 3.02M | 2.20M | 1.99M | 2.87M |
| Other Current Liabilities | 28.00K | 744.00K | 739.00K | |||
| Total Current Liabilities | 7.87M | 8.44M | 15.86M | 20.46M | 23.12M | 21.33M |
| Long-Term Leases | 18.53M | 20.13M | 22.96M | 17.44M | 20.22M | 21.85M |
| Long-Term Unearned Revenue | 1.17M | 1.54M | 3.62M | 9.11M | 12.92M | 14.21M |
| Other Long-Term Liabilities | 132.00K | 132.00K | 43.00K | 42.00K | 210.00K | |
| Total Liabilities | 27.70M | 30.24M | 42.43M | 47.04M | 56.30M | 57.60M |
| Additional Paid-In Capital | 488.43M | 487.31M | 484.50M | 476.99M | 467.51M | 457.43M |
| Retained Earnings | -475.74M | -460.78M | -427.40M | -364.29M | -295.09M | -206.99M |
| Comprehensive Income & Other | -44.00K | -21.00K | 97.00K | 37.00K | -919.00K | -321.00K |
| Total Common Equity | 12.64M | 26.50M | 57.20M | 112.74M | 171.51M | 250.12M |
| Shareholders' Equity | 12.64M | 26.50M | 57.20M | 112.74M | 171.51M | 250.12M |
| Total Liabilities & Equity | 40.34M | 56.75M | 99.63M | 159.78M | 227.81M | 307.72M |
| Total Debt | 21.62M | 22.96M | 25.21M | 20.22M | 22.61M | 24.36M |
| Net Cash (Debt) | -4.03M | 4.55M | 22.11M | 81.97M | 146.28M | 161.86M |
| Net Cash Per Share | -2.30 | 2.43 | 11.58 | 43.36 | 78.31 | 97.52 |
| Filing Date Shares Outstanding | 1.93M | 1.92M | 1.92M | 1.91M | 1.89M | 1.87M |
| Total Common Shares Outstanding | 1.93M | 1.92M | 1.92M | 1.91M | 1.89M | 1.87M |
| Working Capital | 12.70M | 21.82M | 34.96M | 85.25M | 149.63M | 167.83M |
| Book Value Per Share | 6.56 | 13.80 | 29.84 | 59.16 | 90.75 | 133.75 |
| Tangible Book Value | 12.64M | 26.50M | 57.20M | 112.74M | 171.51M | 250.12M |
| Tangible Book Value Per Share | 6.56 | 13.80 | 29.84 | 59.16 | 90.75 | 133.75 |
| Machinery | 3.83M | 8.27M | 10.13M | 10.42M | 10.10M | 8.26M |
| Leasehold Improvements | 358.00K | 358.00K | 286.00K | 285.00K | 272.00K | 145.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -28.74M | -33.38M | -63.12M | -69.20M | -88.10M | -98.59M |
| Depreciation & Amortization | 919.00K | 1.29M | 1.78M | 1.85M | 1.67M | 1.19M |
| Loss (Gain) From Sale of Assets | -404.00K | -288.00K | -70.00K | 108.00K | ||
| Asset Writedown & Restructuring Costs | 808.00K | 1.47M | ||||
| Loss (Gain) From Sale of Investments | -413.00K | -670.00K | -2.62M | -4.49M | 184.00K | 2.65M |
| Stock-Based Compensation | 2.54M | 2.78M | 7.41M | 9.22M | 9.58M | 8.50M |
| Other Operating Activities | 2.63M | 2.53M | 2.30M | 2.95M | 3.23M | 8.56M |
| Change in Accounts Payable | -3.28M | -5.43M | -4.88M | -3.41M | 2.77M | 6.68M |
| Change in Unearned Revenue | -3.11M | -4.64M | -4.67M | -3.61M | -2.16M | 15.57M |
| Change in Other Net Operating Assets | -2.41M | -2.04M | 1.12M | -2.85M | -3.66M | -1.74M |
| Operating Cash Flow | -31.45M | -39.85M | -61.29M | -69.53M | -76.50M | -57.07M |
| Capital Expenditures | -85.00K | -72.00K | -41.00K | -206.00K | -1.95M | -2.34M |
| Sale of Property, Plant & Equipment | 717.00K | 963.00K | 148.00K | |||
| Investment in Securities | 34.02M | 43.41M | 57.47M | 71.24M | 59.81M | -229.86M |
| Investing Cash Flow | 34.65M | 44.30M | 57.58M | 71.04M | 57.86M | -232.20M |
| Issuance of Common Stock | 30.00K | 19.00K | 108.00K | 253.00K | 503.00K | 259.21M |
| Financing Cash Flow | 30.00K | 19.00K | 108.00K | 253.00K | 503.00K | 311.11M |
| Net Cash Flow | 3.23M | 4.47M | -3.60M | 1.77M | -18.14M | 21.84M |
| Free Cash Flow | -31.54M | -39.92M | -61.33M | -69.73M | -78.46M | -59.40M |
| Free Cash Flow Margin | -670.98% | -518.80% | -797.53% | -885.36% | -1,369.47% | -4,714.60% |
| Free Cash Flow Per Share | -17.98 | -21.35 | -32.12 | -36.88 | -42.00 | -35.79 |
| Levered Free Cash Flow | -18.79M | -24.90M | -37.54M | -39.47M | -46.18M | -41.99M |
| Unlevered Free Cash Flow | -18.79M | -24.90M | -37.54M | -39.47M | -46.18M | -41.99M |
| Change in Working Capital | -8.80M | -12.12M | -8.44M | -9.86M | -3.06M | 20.51M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 16.13M | 10.50M | 20.48M | 42.52M | 48.96M | 182.69M |
| Enterprise Value | 2.17M | -15.14M | -56.35M | -98.93M | -5.27M | |
| Last Close Price | 6.24 | 5.47 | 10.70 | 22.40 | 26.00 | 98.00 |
| PS Ratio | 1.36 | 2.66 | 5.40 | 8.55 | 145.00 | |
| PB Ratio | 0.40 | 0.36 | 0.38 | 0.28 | 0.73 | |
| P/TBV Ratio | 0.40 | 0.36 | 0.38 | 0.28 | 0.73 | |
| EV/Sales Ratio | 0.28 | |||||
| Debt / Equity Ratio | 1.71 | 0.87 | 0.44 | 0.18 | 0.13 | 0.10 |
| Net Debt / Equity Ratio | 0.32 | -0.17 | -0.39 | -0.73 | -0.85 | -0.65 |
| Net Debt / EBITDA Ratio | -0.15 | 0.14 | 0.33 | 1.10 | 1.65 | 1.77 |
| Net Debt / FCF Ratio | -0.13 | 0.11 | 0.36 | 1.18 | 1.86 | 2.73 |
| Asset Turnover | 0.08 | 0.10 | 0.06 | 0.04 | 0.02 | 0.01 |
| Quick Ratio | 2.24 | 3.38 | 3.06 | 5.03 | 7.30 | 8.73 |
| Current Ratio | 2.61 | 3.59 | 3.21 | 5.17 | 7.47 | 8.87 |
| Return on Equity (ROE) | -111.65% | -79.75% | -74.28% | -48.69% | -41.79% | -71.52% |
| Return on Assets (ROA) | -30.73% | -27.68% | -32.88% | -24.57% | -21.08% | -32.74% |
| Return on Capital Employed (ROCE) | -87.70% | -71.70% | -81.50% | -54.70% | -44.10% | -32.40% |
| Earnings Yield | -318.00% | -308.19% | -162.73% | -179.94% | -53.96% | |
| FCF Yield | -195.46% | -380.37% | -299.47% | -163.99% | -160.25% | -32.52% |
| Buyback Yield / Dilution | 8.42% | 2.06% | -0.98% | -1.21% | -12.54% | -1,479.05% |